
Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity
London
Joined December 2018
- Tweets6.2K
- Following2.3K
- Followers19K
- Likes3K
Niagen Bioscience’s new Niagen Plus vial comes pre-filled and needs no mixing. It is available via a telehealth platform from 22 October.
vist.ly/5pnyu
#longevity #NiagenBioscience #NiagenPlus #telehealth #NAD
As its CEO takes the stage in Berlin, the company opens a window on its longest-lived treated mice – and the data behind them.
vist.ly/5pnjc
#longevity #geroscience #lifespan #longevityresearch #preclinical
Cognition Therapeutics wins a US patent on a new crystal form of zervimesine and has an FDA meeting on its Lewy body trial lined up.
vist.ly/5pn4e
#longevity #geroscience #CognitionTherapeutics #zervimesine #Lewybody
Zealand Pharma and Generate Biomedicines will design multispecific proteins for metabolic disease, in a deal with nearly $1.2b in milestones.
vist.ly/5pmu2
#longevity #ZealandPharma #GenerateBiomedicines #metabolicdisease #biotech
Berlin keynote details Eos SENOLYTIX’s pre-clinical results with mitochondrial-targeted geropeptide on healthspan and lifespan.
vist.ly/5pmq2
#longevity #geroscience #EosSENOLYTIX #healthspan #lifespan
What if how well we function matters as much as what’s been diagnosed?
Dr John Beard explains why intrinsic capacity could change how we think about aging and care.
#longevity #geroscience #intrinsiccapacity
As pharma shops for de-risked science, venture money is moving later and concentrating in fewer, bigger bets – our report tracks the shift.
vist.ly/5pi6t
#longevity #geroscience #pharma #venturecapital #biotech
Avaí Bio and Austrianova began work with Ospedale San Raffaele on protecting lab-grown insulin cells from the immune system.
vist.ly/5phkd
#longevity #geroscience #AvaíBio #Austrianova #insulin
Nature Biotechnology paper offers a better way to judge models that predict gene effects. Shift plans to use it to hunt for aging targets.
vist.ly/5ph3v
#longevity #geroscience #NatureBiotechnology #geneeffects #aging
Insilico Medicine nominates ISM9546, an oral VAV1 degrader designed with generative AI, as a preclinical candidate for autoimmune disease.
vist.ly/5pghr
#longevity #geroscience #InsilicoMedicine #ISM9546 #autoimmunedisease
KAUST and Oxford researchers used a transistor-based sensor to read three forms of alpha-synuclein, reaching 90.9% accuracy in a small study.
vist.ly/5pgbw
#longevity #geroscience #KAUST #Oxford #alphasynuclein
Rona Therapeutics grants Roche worldwide rights to an ALK7-silencing candidate, with up to $1.06b in further milestones on the table.
vist.ly/5pg62
#longevity #RonaTherapeutics #Roche #ALK7 #biotech
Intrinsic capacity isn’t simply fitness, independence or being disease-free.
It spans cognition, locomotion, psychological and sensory capacity, and vitality, but there’s no universally accepted composite score yet.
#longevity #geroscience #intrinsiccapacity
An up to $28.3 million ARPA-H award aims to stretch Bexorg’s human brain platform from 24 hours to two weeks.
vist.ly/5pcav
#longevity #geroscience #ARPAH #Bexorg #brainresearch
German biotech MODAG won for pairing a CE-marked diagnostic with a drug candidate that targets the same protein.
vist.ly/5pbv5
#longevity #geroscience #MODAG #biotech #diagnostics
Adjusting for how advanced patients’ disease was at the start lifts the Phase 2 result. The method was added after the trial began.
vist.ly/5pbbj
#longevity #geroscience #Phase2 #clinicaltrial #clinicalresearch
Cala Health’s kIQ Plus now offers three stimulation modes and a calibration before each use, and it’s available across the US.
vist.ly/5pb5h
#longevity #CalaHealth #kIQPlus #stimulation #digitalhealth
Buck Institute’s Eric Verdin joins clinic leaders to tackle the ‘luxury diagnostic’ trap and the push for standardized care.
vist.ly/5pax4
#longevity #geroscience #BuckInstitute #EricVerdin #standardizedcare
BodySpec’s new storefront targets muscle loss from GLP-1 weight loss drugs, with scans said to take about 12 minutes.
vist.ly/5p8bg
#longevity #bodyspec #muscleloss #glp1 #weightloss
VectorY is growing PIONEER-ALS from 12 to 36 participants to test VTx-002, an antibody therapy aimed at the protein TDP-43.
vist.ly/5p7v2
#longevity #geroscience #vectory #pioneerals #vtx002






















